SecBot SecBot
DEFA14A ·Filed Mar 18, 2026

BSX

BOSTON SCIENTIFIC CORP
NEUTRAL
Impact 3/10
Horizonweeks Processed8mo ago SEC0000885725-26-000027
Proxy solicitation materials
Actionable Insight • Neutral

Traders should await the full proxy filing to assess potential governance risks or changes in leadership/compensation that could influence investor sentiment. Monitor for any activist shareholder initiatives or dissident nominations once the document is available.

DirectionNeutral
Confidencelow
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$69.88
T+0 close · Mar 18, 2026 · via day close
Latest settled
−33.12%
T+60 · $46.74
Vs SPY
−47.46%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 19 $69.88entry
  2. T+1 · 8mo ago −0.59%α +1.15% · $69.47
  3. T+5 · 8mo ago +0.37%α +2.58% · $70.14
  4. T+20 · 7mo ago −8.10%α −15.72% · $64.22
  5. T+60 · 5mo ago −33.12%α −47.46% · $46.74
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable. This DEFA14A filing by Boston Scientific Corp (BSX) relates to a proxy statement for a shareholder vote, likely concerning director elections, executive compensation, or other corporate governance matters. Without access to the full filing, specific details on proposals or activist involvement cannot be determined.

Key Facts

  • Filing type DEFA14A indicates this is a definitive proxy statement for a shareholder meeting.
  • Typically includes information on director nominees, executive compensation, and shareholder proposals.
  • No document content available to confirm specific agenda items or voting recommendations.
  • Recent insider buying observed in congressional trades, though not necessarily linked to this filing.

Financial Impact

Not specified

Risk Factors

  • Lack of transparency due to missing filing content limits ability to assess material governance developments.
  • Potential for unexpected shareholder proposals or management controversies not yet disclosed.

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

Report based on filing metadata.

Track record

22 reports on BSX

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +9.24% at T+20 after the Aug 26, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Oct 28, 202619d ago 8-K Bearish 6/10 No price data
  2. Oct 28, 202619d ago Press Release Bearish 5/10 Entry $42.43 Now $43.69 −2.97% settles Nov 25
  3. Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $45.69 Now $43.69 +4.38% settles Nov 20
  4. Oct 7, 20265w ago 8-K Mixed 6/10 Entry $41.58 to $45.82 Now $43.69 +5.07% ▲ +10.20% +11.54% vs SPY
  5. Sep 23, 20267w ago 8-K Bearish 5/10 Entry $44.62 to $44.51 Now $43.69 +2.08% ▲ +0.25% +0.93% vs SPY
  6. Aug 31, 202611w ago Court Ruling Neutral 2/10 Entry $48.08 to $43.65 Now $43.69 −9.13% ▼ −9.21% −9.57% vs SPY
  7. Aug 26, 202611w ago 8-K Bearish 6/10 Entry $48.17 to $43.72 Now $43.69 +9.30% ▲ +9.24% +10.44% vs SPY
  8. Aug 22, 202612w ago Institutional Cluster Mixed 6/10 Entry $49.01 to $44.92 Now $43.69 −10.85% ▼ −8.35% −9.66% vs SPY
  9. Aug 7, 202614w ago Insider Cluster Mixed 6/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
  10. Aug 7, 202614w ago Insider Cluster Mixed 5/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens Wed (11h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 18, 2026